DengYue Medicine (DengYueMed/Hong Kong Dengyue Pharmaceutical Limited), founded in 2019, is located in Hong Kong SAR. DengYue is licensed by the Department of Health of Hong Kong to take photos of pharmaceutical import and export wholesalers, specializing in the import and export of new and specialty drugs as well as isolated drugs in the field of major chronic diseases.
-
3 Δημοσιεύσεις
-
1 τις φωτογραφίες μου
-
0 Videos
-
ζει στην Hong Kong
-
Από 6/F, Tai Tak Industrial Building, New Territories,
-
Male
-
08/01/2005
-
ακολουθείται από 1 μέλη
© 2025 Telodosocial – Condividi ricordi, connettiti e crea nuove amicizie,eldosocial – Share memories, connect and make new friends
Greek
Πρόσφατες ενημερώσεις
-
Top 10 Chinese Exporters of Finished Pharmaceutical Products (2025 Compiled by Dengyue Pharmaceuticals)As we step into the latter half of 2025, China's pharmaceutical industry continues to assert its dominance on the global stage. With total pharmaceutical exports reaching new heights amid recovering global supply chains, Chinese companies are leading in the production and export of finished pharmaceutical products, including generics, vaccines, and innovative therapies. According to recent...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 ΠροεπισκόπησηΠαρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
Ionis Launches Tryngolza™ (Olezarsen) for FCS With Positive Phase 3 Data and $595,000 Annual List PriceIonis Pharmaceuticals, Inc. (NASDAQ: IONS) today announced the official U.S. launch of Tryngolza™ (olezarsen), a novel, once-monthly RNA-targeted therapy for familial chylomicronemia syndrome (FCS). The drug enters the market at an annual list price of $595,000, following its FDA approval in December 2024. First FDA-Approved Olezarsen Therapy for...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση
-
0 Σχόλια 0 Μοιράστηκε 811 Views 0 Προεπισκόπηση
και άλλες ιστορίες
Προωθημένο